Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Aug 5;7(299):299rv4.
doi: 10.1126/scitranslmed.aaa7322.

Immune-mediated pathology in Duchenne muscular dystrophy

Amy S Rosenberg  1 , Montserrat Puig  2 , Kanneboyina Nagaraju  3 , Eric P Hoffman  3 , S Armando Villalta  4 , V Ashutosh Rao  2 , Lalage M Wakefield  5 , Janet Woodcock  2
Affiliations
Review

Immune-mediated pathology in Duchenne muscular dystrophy

Amy S Rosenberg et al. Sci Transl Med. .

Abstract

Immunological and inflammatory processes downstream of dystrophin deficiency as well as metabolic abnormalities, defective autophagy, and loss of regenerative capacity all contribute to muscle pathology in Duchenne muscular dystrophy (DMD). These downstream cascades offer potential avenues for pharmacological intervention. Modulating the inflammatory response and inducing immunological tolerance to de novo dystrophin expression will be critical to the success of dystrophin-replacement therapies. This Review focuses on the role of the inflammatory response in DMD pathogenesis and opportunities for clinical intervention.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1. Initiation and perpetuation of inflammatory responses in dystrophic muscle
Dystrophin-deficient muscle cells are susceptible to contraction-induced injury, culminating in muscle necrosis and the release of DAMP molecules including ATP (adenosine 5′-triphosphate) and nucleic acids. Released muscle proteins may serve as neoantigens. Engagement by DAMPs of TLR7 and the ionotropic receptor P2X7 on skeletal muscle cells and macrophages triggers innate immune activation and a chronic inflammatory response. Concomitantly, MHC presentation of peptides derived from muscle antigens initiates an adaptive immune response. Cytokines and chemokines released in the milieu attract and activate additional infiltrating immune cells including neutrophils and antigen presenting cells (APCs), such as M1 macrophages and dendritic cells. The APCs, in turn, activate recruited lymphocytes (CD4+ and CD8+ T cells), leading to propagation of adaptive immune responses (TH1, TH2), which are dampened by Tregs. Although B cells have been detected in DMD muscle, there is no known role for B cells in antigen presentation or antibody production in the context of DMD. The balance between the TH1 and the TH2 adaptive immune response creates a regulatory feedback mechanism that leads to activation of either M1 or M2 macrophages, which affects the severity of muscle inflammation or the efficiency of muscle regeneration, respectively.
Fig. 2
Fig. 2. Normal but not dystrophic skeletal muscle regenerates after injury
(A) Stages of regeneration in normal mouse muscle after injury. Regeneration of skeletal muscle in response to injury is a highly synchronized process. Within 24 hours of injury, mouse muscle becomes infiltrated with neutrophils. Within 2 to 3 days, the injured muscle is infiltrated by pro-inflammatory M1 macrophages. During days 5 to 10, the resolution and repair phases of regeneration take place and muscle is predominantly populated by remodeling M2 macrophages. M2 macrophages are essential for complete muscle regeneration, which is achieved by day 14. (B) Asynchronous degeneration/regeneration in human dystrophin-deficient muscle. Repair of human dystrophin-deficient muscle after injury is impaired due to asynchronous bouts of degeneration and regeneration, leading to the release of cytokines, such as TGF-β, that initiate and perpetuate fibrosis. Shown is a muscle biopsy from a DMD patient revealing regions of nearly normal myofibers; chronic inflammation (between myofibers); phagocytosis by neutrophils and macrophages, and necrosis; and fibrosis (failed regeneration).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Kornegay JN, Childers MK, Bogan DJ, Bogan JR, Nghiem P, Wang J, Fan Z, Howard JF, Jr, Schatzberg SJ, Dow JL, Grange RW, Styner MA, Hoffman EP, Wagner KR. The paradox of muscle hypertrophy in muscular dystrophy. Phys Med Rehabil Clin N Am. 2012;23:149–172. - PMC - PubMed
    1. National Center for Immunization, Respiratory Diseases. General recommendations on immunization—Recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep. 2011;60:1–64. - PubMed
    1. Pétrilli V, Dostert C, Muruve DA, Tschopp J. The inflammasome: A danger sensing complex triggering innate immunity. Curr Opin Immunol. 2007;19:615–622. - PubMed
    1. Hyldahl RD, Nelson B, Xin L, Welling T, Groscost L, Hubal MJ, Chipkin S, Clarkson PM, Parcell AC. Extracellular matrix remodeling and its contribution to protective adaptation following lengthening contractions in human muscle. FASEB J. 2015;29:2894–2904. - PubMed
    1. Dadgar S, Wang Z, Johnston H, Kesari A, Nagaraju K, Chen YW, Hill DA, Partridge TA, Giri M, Freishtat RJ, Nazarian J, Xuan J, Wang Y, Hoffman EP. Asynchronous remodeling is a driver of failed regeneration in Duchenne muscular dystrophy. J Cell Biol. 2014;207:139–158. - PMC - PubMed

MeSH terms